State UT
Clinical Trials in Utah
Utah is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Utah and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 187 actively recruiting studies with Utah sites out of 187 registered in total. The busiest research areas in Utah are Multiple Myeloma, Heart Failure, Non-small Cell Lung Cancer. Leading sponsors running trials in the state include University of Utah, AstraZeneca, National Cancer Institute (NCI). By stage, Utah trials break down as Phase 1 (41), Phase 2 (58), Phase 3 (49), Phase 4 (2).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Utah
Frequently Asked Questions — Clinical Trials in Utah
How many clinical trials are currently recruiting in Utah?
ClinicalMetric currently tracks 187 actively recruiting clinical trials with at least one location in Utah. The total number of registered studies—including active but not currently enrolling trials—is 187. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Utah?
Utah hosts clinical trials across a broad range of medical conditions, including Multiple Myeloma, Heart Failure, Non-small Cell Lung Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Utah serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Utah?
To join a clinical trial in Utah, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Utah maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Utah
NCT07599982 N/A
Recruiting
Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabet...
Condition
Type 1 Diabetes (T1D)
Enrollment
102 pts
Location
United States
Sponsor
DreaMed Diabetes
NCT06303505 Phase 1, Phase 2
Recruiting
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Pa...
Condition
Ovarian Cancer
Enrollment
334 pts
Location
United States, Belgium, Germany
Sponsor
Gilead Sciences
NCT07186101 Phase 2
Recruiting
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately ...
Condition
Ulcerative Colitis
Enrollment
252 pts
Location
United States, Austria, Brazil
Sponsor
Eli Lilly and Company
NCT07204275 Phase 2, Phase 3
Recruiting
Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants...
Condition
Primary Membranous Nephropathy
Enrollment
176 pts
Location
United States, Australia, Brazil
Sponsor
Vertex Pharmaceuticals Incorpo
NCT07085767 Phase 3
Recruiting
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/...
Condition
Breast Cancer
Enrollment
1,000 pts
Location
United States, Australia, Austria
Sponsor
Olema Pharmaceuticals, Inc.
NCT07174466 N/A
Recruiting
The e-SINCERE Study
Condition
Social Determinants of Health (SDOH)
Enrollment
600 pts
Location
United States
Sponsor
Andrea Wallace
NCT07232602 Phase 1, Phase 2
Recruiting
KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortu...
Condition
Bladder Cancer
Enrollment
55 pts
Location
United States, Chile, France
Sponsor
Merck Sharp & Dohme LLC
NCT05826535 Phase 1, Phase 2
Recruiting
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Condition
Relapsed Non-Hodgkin Lymphoma
Enrollment
270 pts
Location
United States, Australia
Sponsor
Lyell Immunopharma, Inc.
NCT07573176 Phase 3
Recruiting
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Ma...
Condition
Depressive Disorder, Major
Enrollment
600 pts
Location
United States, Argentina, Brazil
Sponsor
Janssen Research & Development
NCT06387290 Phase 3
Recruiting
Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits
Condition
Chronic Pain
Enrollment
300 pts
Location
United States
Sponsor
University of Utah
NCT06636383 N/A
Recruiting
Glycogen Storage Disease Type Ia (GSDIa) Disease Monitoring Program
Condition
Glycogen Storage Disease Type Ia
Enrollment
140 pts
Location
United States, Brazil, Canada
Sponsor
Ultragenyx Pharmaceutical Inc
NCT07817251 Phase 3
Recruiting
Research Study on How People With Type 2 Diabetes Tolerate Switching From Semagl...
Condition
Diabetes Mellitus, Type 2
Enrollment
210 pts
Location
United States
Sponsor
Novo Nordisk A/S
NCT06881069 N/A
Recruiting
Reach Through Equitable Implementation in Utah
Condition
Tobacco Use Cessation
Enrollment
1,560 pts
Location
United States
Sponsor
University of Utah
NCT07609394 N/A
Recruiting
Duchenne Electronic Health Record Study
Condition
Duchenne Muscular Dystrophy (DMD)
Enrollment
2,500 pts
Location
United States
Sponsor
The Duchenne Registry
NCT04187729 N/A
Recruiting
Precision Genomics Medicine Biobank
Condition
Any Disease Condition and Reportedly-healthy Subjects
Enrollment
100,000 pts
Location
United States
Sponsor
Intermountain Health Care, Inc
NCT06767514 Phase 3
Recruiting
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patie...
Condition
Non-Small Cell Lung Cancer
Enrollment
780 pts
Location
United States, Belgium, Canada
Sponsor
Summit Therapeutics
NCT06740630 Phase 3
Recruiting
A Study on the Immune Response and Safety of an Investigational Chickenpox Vacci...
Condition
Chickenpox
Enrollment
1,840 pts
Location
United States, Belgium, Colombia
Sponsor
GlaxoSmithKline
NCT07421700 Phase 1, Phase 2
Recruiting
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With...
Condition
Urothelial Cancer
Enrollment
132 pts
Location
United States, Australia, China
Sponsor
Pfizer
NCT07196644 Phase 2
Recruiting
A Study to Assess Adverse Events and Change in Disease Activity in Participants ...
Condition
Solid Tumors Harboring MET Amplification
Enrollment
100 pts
Location
United States, Israel, Japan
Sponsor
AbbVie
NCT06602271 Phase 3
Recruiting
PF614 Analgesic Activity in Acute Postoperative Pain (PF614-301)
Condition
Postoperative Pain, Acute
Enrollment
320 pts
Location
United States
Sponsor
Ensysce Biosciences
NCT06381674 N/A
Recruiting
Wearable Technology to Characterize and Treat mTBI Subtypes: Biofeedback-Based P...
Condition
Mild Traumatic Brain Injury, Concussion
Enrollment
100 pts
Location
United States
Sponsor
Oregon Health and Science Univ
NCT06736574 Phase 3
Recruiting
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With S...
Condition
Heart Failure
Enrollment
1,800 pts
Location
United States, Canada, China
Sponsor
Cytokinetics
NCT04372615 Phase 2
Recruiting
The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis
Condition
Autoimmune Encephalitis
Enrollment
116 pts
Location
United States, Netherlands, Spain
Sponsor
University of Utah
NCT07090785 Phase 1
Recruiting
A Study of LY4088044 in Healthy Participants
Condition
Healthy
Enrollment
104 pts
Location
United States, New Zealand, Singapore
Sponsor
Eli Lilly and Company
NCT07629440 Phase 3
Recruiting
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.
Condition
Pneumococcal Disease
Enrollment
3,230 pts
Location
United States, Japan, Puerto Rico
Sponsor
Pfizer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology